Lv1
50 积分 2024-05-10 加入
Inflammasome components as new therapeutic targets in inflammatory disease
13天前
已完结
[Updates in the 5(th) edition of WHO classification of tumours of the breast]
19天前
已完结
美国临床肿瘤学会／美国病理医师学院乳腺癌雌、孕激素受体免疫组织化学检测指南简介
20天前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
1个月前
已完结
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
2个月前
已完结
Exploiting the folate receptor α in oncology
3个月前
已完结
Evolution of low HER2 expression between early and advanced-stage breast cancer
3个月前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
3个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
4个月前
已完结
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations
6个月前
已完结
皖公网安备34019202002308
